All In Biotech

Drug Trial Radar · NCT06825702

Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema

A Phase 2, Open-label, Multiple Dose Study of the Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema (KLARITY-1)

Last checked: Nov 19, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

28

Planned (sponsor's estimate)

Start

May 1, 2025

Primary completion

Nov 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Kiora Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Feb 13, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, open label study to assess the safety, tolerability, and efficacy of KIO-104 administered by IVT injection to the study eye of eligible participants with macular edema.

Conditions

  • Macular Edema

Interventions

  • KIO-104Drug

    KIO-104 is an ophthalmic formulation for IVT injection of the active pharmaceutical ingredient (API) KIO-100, a novel, non-steroidal, small molecule inhibitor of dihydroorotate dehydrogenase (DHODH).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and TolerabilityTime frame: 23months

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Sydney Eye Hospital

    Sydney, New South Wales, Australia · Recruiting

  • Sydney West Retina

    Westmead, New South Wales, Australia · Recruiting

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia · Recruiting

  • Hobart Eye Surgeons

    Hobart, Tasmania, Australia · Recruiting

  • Centre for Eye Research Australia

    East Melbourne, Victoria, Australia · Recruiting

  • Lions Eye Institute Limited

    Nedlands, Western Australia, Australia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.